Neurocrine Biosciences Inc Balance Sheet

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020
Assets
Current Assets
Cash & Equivalents 37.33M54.05M50.11M63.75M44.79M31.01M74.19M83.27M254.71M141.71M112.30M190.30M
Short-term Investments 72.81M79.00M109.26M100.95M162.79M305.00M224.08M261.22M509.20M558.20M613.90M
Cash & Current Investments 37.33M126.86M129.10M173.01M145.74M193.81M379.19M307.35M515.93M650.91M670.50M804.20M
Receivables - Net 4.47M1.90M14.09M2.72M31.13M57.41M126.60M157.10M
Receivables - Other 3.70M
Receivables 4.47M1.90M14.09M2.72M31.13M57.41M126.60M160.80M
Raw Materials 7.86M14.10M16.60M
Work In Process 0.49M2.21M1.50M2.40M
Finished Goods 0.53M0.80M1.70M9.00M
Inventory 1.02M10.86M17.30M28.00M
Prepaid Assets 1.72M1.47M2.16M2.72M4.39M4.88M3.09M6.84M18.59M16.60M30.10M
Current Assets 133.05M132.48M189.26M148.46M198.20M384.07M310.44M554.92M737.78M831.00M1,016.20M
Non-Current Assets
Property, Plant & Equipment (Net) 1.53M1.59M1.90M1.77M2.51M3.43M6.27M10.81M33.87M41.90M44.60M
Long-Term Investments 3.74M0.48M101.00M37.49M82.49M43.49M247.36M216.03M299.70M227.10M
Long-Term Deferred Tax 325.30M319.40M
Other Non-Current Assets 6.10M4.31M4.33M4.44M4.83M4.79M4.88M4.50M5.48M115.50M6.40M
Non-Current Assets 11.37M5.89M6.71M6.21M44.83M90.71M54.64M262.67M255.37M475.00M718.50M
Assets 144.42M138.37M195.98M154.68M243.03M474.79M365.09M817.59M993.15M1,306.00M1,734.70M
Liabilities
Current Liabilities
Accounts Payables 0.81M1.11M0.91M0.10M0.25M2.56M26.18M53.52M86.38M141.30M168.70M
Payables 0.81M1.11M0.91M0.10M0.25M2.56M26.18M53.52M86.38M141.30M168.70M
Accumulated Expenses 8.60M8.45M8.09M7.96M11.51M19.03M9.56M24.90M27.34M38.94M
Other Accumulated Expenses 3.13M3.05M3.17M3.28M4.32M6.00M18.17M1.86M15.20M17.80M
Short term Debt 408.80M
Current Leases 3.38M0.26M0.59M0.42M0.47M0.43M0.24M0.06M
Current Deferred Revenue 37.03M34.24M3.13M3.23M3.32M10.20M3.53M0.73M
Total Current Liabilities 52.78M47.11M15.65M11.70M15.66M25.71M30.41M54.43M88.23M565.30M186.50M
Non-Current Liabilities
Capital Leases 6.58M2.33M3.10M2.68M2.21M1.55M0.62M
Convertible Debt 369.62M388.50M408.80M317.90M
Non-Current Deffered Revenue 37.16M2.92M1.84M1.98M1.88M10.23M10.23M10.23M18.11M
Operating Leases 86.70M94.40M
Other Non-Current Liabilities 0.10M0.12M0.15M0.26M0.26M0.22M0.11M35.66M17.10M9.70M
Total Non-Current Liabilities 124.98M78.16M41.45M34.01M34.07M50.11M50.10M476.73M652.00M598.80M
Total Liabilities 125.08M78.29M41.61M34.27M34.33M50.33M50.21M445.45M512.39M669.10M608.50M
Shareholder's Equity
Total Debt 408.80M
Common Equity 3.95M19.34M60.08M154.37M120.41M208.70M424.45M314.88M372.14M480.76M636.90M1,126.20M
Shareholder's Equity 3.95M19.34M60.08M154.37M120.41M208.70M424.45M314.88M372.14M480.76M636.90M1,126.20M
Liabilities and Shareholders Equity 144.42M138.37M195.98M154.68M243.03M474.79M365.09M817.59M993.15M1,306.00M1,734.70M
Retained Earnings -762.27M-724.70M-719.67M-765.76M-826.30M-915.23M-1056.32M-1198.87M-1177.76M-1132.70M-725.40M
Treasury Shares 0.68M0.29M0.05M0.37M0.67M0.91M0.88M1.08M1.13M1.40M1.50M